CSPC Pharmaceutical Group Limited
(Incorporated in Hong Kong with limited liability)

Announcements & Notices       

2016-December-14	VOLUNTARY ANNOUNCEMENT - PRODUCT LICENSING AND CO-DEVELOPMENT AGREEMENT (in PDF)
2016-December-12	VOLUNTARY ANNOUNCEMENT - PRODUCT LICENSING AGREEMENT (in PDF)
2016-November-23	UNAUDITED RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2016 (in PDF)
2016-November-21	INSIDE INFORMATION AND RESUMPTION OF TRADING (in PDF)
2016-November-21	TRADING HALT (in PDF)
2016-November-11	DATE OF BOARD MEETING (in PDF)
2016-August-26	COMPLETION OF EXERCISE OF THE EXISTING SHARE OPTIONS (in PDF)
2016-August-23	2016 INTERIM RESULTS ANNOUNCEMENT (in PDF)
2016-August-11	DATE OF BOARD MEETING (in PDF)
2016-June-27	CONTINUING CONNECTED TRANSACTIONS - LEASE AGREEMENTS (in PDF)
2016-June-13	(1) COMPLETION OF THE ACQUISITION OF 93.18% EQUITY INTEREST IN CSPC SHENGXUE GLUCOSE CO., LTD. AND (2) CONTINUING CONNECTED TRANSACTIONS (in PDF)
2016-June-6	LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (in PDF)
2016-June-6	APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND COMPLIANCE WITH RULE 3.10A OF THE LISTING RULES (in PDF)
2016-May-30	POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 30 MAY 2016 (in PDF)
2016-May-18	UNAUDITED RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2016 (in PDF)
2016-May-6	DATE OF BOARD MEETING (in PDF)
2016-April-25	VOLUNTARY ANNOUNCEMENT - PRODUCT TECHNOLOGY LICENSING AGREEMENT (in PDF)
2016-April-21	NOTICE OF ANNUAL GENERAL MEETING (in PDF)
2016-April-20	VOLUNTARY ANNOUNCEMENT - THE GROUP'S CHEMICAL DRUG "BUTYLPHTHALIDE SOFT CAPSULES" WAS GRANTED CLINICAL TRIAL APPROVAL IN RELATION TO A NEW INDICATION FOR VASCULAR DEMENTIA (in PDF)
2016-April-20	VOLUNTARY ANNOUNCEMENT-CLARIFICATION OF ARTICLES (in PDF)
2016-April-14	CONNECTED TRANSACTION - ACQUISITION OF 93.18% EQUITY INTEREST IN CSPC SHENGXUE GLUCOSE CO., LTD. (in PDF)
2016-April-8	NON-COMPLIANCE WITH RULE 3.10A OF THE LISTING RULES (in PDF)
2016-March-21	ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2015 (in PDF)
2016-March-9	DATE OF BOARD MEETING (in PDF)
2016-February-25	VOLUNTARY ANNOUNCEMENT - THE GROUP'S ONCOLOGY DRUG "SKLB1028 CAPSULES" WAS GRANTED CLINICAL TRIAL APPROVAL (in PDF)
2016-February-5	VOLUNTARY ANNOUNCEMENT - APPROVAL GRANTED FOR THE COMMENCEMENT OF CLINICAL TRIALS FOR THE GROUP'S PRODUCTS (in PDF)
2016-January-11	LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (in PDF)
2016-January-8	RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND NON-COMPLIANCE WITH RULE 3.10A OF THE LISTING RULES (in PDF)
2024	2024 Announcements & Notices
2023	2023 Announcements & Notices
2022	2022 Announcements & Notices
2021	2021 Announcements & Notices
2020	2020 Announcements & Notices
2019	2019 Announcements & Notices
2018	2018 Announcements & Notices
2017	2017 Announcements & Notices
2015	2015 Announcements & Notices
2014	2014 Announcements & Notices
2013	2013 Announcements & Notices
2012	2012 Announcements & Notices
2011	2011 Announcements & Notices
2010	2010 Announcements & Notices
2009	2009 Announcements & Notices
2008	2008 Announcements & Notices
2007	2007 Announcements & Notices
2006	2006 Announcements & Notices